Revising the classification criteria for systemic sclerosis [3]

Arthritis Care and Research

Volumn 55, Issue 6, 2006, Pages 992-993

  Nadashkevich, O ^a   Davis, P ^b   Fritzler, M J ^c  

^a DANYLO HALYTSKY LVIV NATIONAL MEDICAL UNIVERSITY   (Ukraine)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CENTROMERE PROTEIN ANTIBODY; DNA TOPOISOMERASE; FIBRILLARIN; FIBRILLARIN ANTIBODY; PROTEIN ANTIBODY; SCL 70 ANTIBODY;

DISEASE CLASSIFICATION; HUMAN; LETTER; RHEUMATIC DISEASE; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SYNDROME CREST; SYSTEMIC SCLEROSIS;

HUMANS; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC;

EID: 33845475861     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22364     Document Type: Letter

References (14)

1. Classification and Response Criteria Subcommittee of the American College of Rheumatology Committee on Quality Measures. Development of classification and response criteria for rheumatic diseases. Arthritis Rheum 2006;55:348-52.
2. Johnson SR, Laxer RM. Classification in systemic sclerosis [editorial]. J Rheumatol 2006;33:840-1.
3. The Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
4. Wigley FM. Systemic sclerosis: clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology. Philadelphia: Mosby; 1998. p. 7.9.1-13.
5. Medsger TA Jr. Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR, editors. Current topics in rheumatology: systemic sclerosis (scleroderma). New York: Gower Medical Publishing; 1985. p. 16-7.
6. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Kreig T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15: 202-5.
7. Masi AT. Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity. J Rheumatol 1988;15:894-8.
8. Poormoghim H, Lucas M, Fertig N, Medsger TA Jr. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients. Arthritis Rheum 2000;43:444-51.
9. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet AR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma [letter]. Arthritis Rheum 2001;44:735-6.
10. Seibold JR. Scleroderma and mixed connective tissue diseases. In: Ruddy S, Harris ED Jr, Sledge CB, editors. Kelley's textbook of rheumatology. Vol. II. 6th ed. Philadelphia: WB Saunders Company; 2001. p. 1211-39.
11. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis [review]. J Rheumatol 2001;28:1573-6.
12. Mitri GM, Lucas M, Fertig N, Steeen VD, Medsger TA Jr. A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203-9.
13. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 1988;15:276-83.
14. Nadashkevich O, Davis P, Fritzler M. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 2004; 10:CR615-21.